bocv
isol
respiratori
tract
nasal
swab
broncho
alveolar
wash
fluid
sampl
evalu
genet
antigen
differ
bocv
respiratori
tract
healthi
clinic
ill
cattl
brd
sign
compar
refer
vaccin
strain
base
spike
protein
code
sequenc
vnt
use
convalesc
antisera
base
studi
bocv
isol
belong
one
two
genom
clade
clade
differenti
antigen
respiratori
isol
oklahoma
studi
divid
genet
differ
three
subclad
refer
enter
bocv
strain
vaccin
strain
clade
current
avail
vaccin
design
control
enter
diseas
base
virus
one
clade
virus
isol
respiratori
tract
studi
belong
clade
bovin
respiratori
diseas
brd
associ
infecti
agent
often
complic
stress
factor
includ
environment
nutrit
transport
commingl
cattl
mix
origin
multipl
herd
sourc
infecti
agent
consid
etiolog
brd
includ
virus
bovin
viru
bovin
respiratori
syncyti
viru
brsv
bovin
viral
diarrhea
viru
bvdv
bovin
adenovirus
bav
bovin
coronavirus
bocv
bacteria
mannheimia
haemolytica
pasteurella
multocida
histophilu
somni
mycoplasma
spp
mani
year
brsv
bvdv
virus
associ
viral
etiolog
brd
contrast
bocv
associ
neonat
enter
diseas
winter
dysenteri
adult
cattl
recent
bocv
respiratori
infect
diseas
receiv
attent
subject
multipl
review
bocv
envelop
nonseg
posit
sens
singl
strand
rna
virus
group
speci
within
coronaviru
genu
coronavirida
famili
bocv
virion
contain
larg
surfac
glycoprotein
refer
spike
protein
integr
membran
protein
small
membran
protein
e
hemagglutininesteras
glycoprotein
nucleocapsid
protein
n
strong
humor
respons
elicit
n
protein
follow
natur
infect
predomin
antigen
involv
viru
neutral
locat
protein
variou
studi
segreg
coronaviru
genu
group
base
sever
criteria
includ
posit
variat
nonstructur
protein
end
genom
antigen
cross
reactiv
process
protein
host
rang
howev
set
guidelin
defin
new
coronaviru
speci
differenti
subgroup
within
exist
speci
state
bocv
initi
associ
outbreak
enter
diseas
recent
bocv
associ
bovin
respiratori
diseas
brd
cattl
pull
treatment
feedlot
well
healthi
cattl
numer
studi
us
studi
bocv
identifi
viru
isol
nasal
swab
bronchoalveolar
lavag
bal
serotest
detect
seroconvers
indic
exposur
bocv
outbreak
brd
inappar
infect
bocv
identifi
pneumon
lung
field
case
often
combin
virus
bacteria
includ
mycoplasma
spp
experiment
bocv
caus
respiratori
tract
lesion
affect
epithelium
turbin
trachea
lung
base
observ
two
differ
present
follow
bocv
exposur
suggest
dual
tropism
bocv
respiratori
digest
tract
cattl
control
measur
bocv
respiratori
diseas
limit
vaccin
avail
bocv
licens
control
neonat
enter
diseas
three
inactiv
vaccin
licens
control
neonat
enter
diseas
use
pregnant
cowsheif
pregnanc
stimul
humor
immun
passiv
immun
newborn
calf
modifi
live
viru
vaccin
contain
bocv
administr
oral
newborn
calf
provid
activ
immun
respons
protect
calf
enter
diseas
licens
bocv
vaccin
us
protect
brd
effect
licens
enter
bocv
vaccin
determin
protect
brd
bocv
challeng
howev
one
us
report
use
mlv
vaccin
contain
bocv
reduc
treatment
brd
method
protect
correl
immun
determin
howev
provid
optim
immun
vaccin
antigen
similar
possibl
circul
virus
appear
import
viru
virus
use
immunogen
control
bocv
brd
align
antigen
genet
bocv
circul
field
purpos
studi
compar
bocv
isol
respiratori
tract
oklahoma
cattl
refer
respiratori
enter
strain
enter
vaccin
strain
antigen
genet
procedur
valid
question
ask
differ
enter
respiratori
strain
isol
bocv
strain
strain
use
replac
add
exist
bcv
enter
vaccin
total
field
strain
bocv
character
includ
sampl
cattl
manifest
brd
sign
collect
healthi
cattl
brd
sign
brd
multipl
sourc
studi
bocv
strain
deriv
tabl
cattl
test
neg
bvdv
ear
notch
immunohistochemistri
use
skin
sampl
calv
auction
market
purchas
calv
commingl
auction
transport
osu
wsbrc
process
receiv
identif
mlv
vaccin
contain
brsv
immunogen
nasal
swab
case
bronchoalveolar
lavag
bal
fluid
collect
process
sampl
collect
repeat
weekli
time
day
cattl
place
pen
repres
group
studi
monitor
sentinel
cattl
treat
brd
sampl
well
sentinel
calv
blood
collect
process
serum
well
convalesc
sera
day
arriv
instanc
multipl
posit
bcv
sampl
anim
either
ns
bal
sequenti
collect
addit
ns
collect
osu
studi
viral
challeng
studi
unrel
bocv
includ
studi
similarli
nasal
swab
sampl
collect
southeastern
us
sourc
cattl
commingl
deliv
research
facil
monitor
brd
studi
includ
studi
approv
osu
institut
anim
care
use
committe
bocv
studi
isol
human
rectal
tumor
hrt
monolay
cultur
filter
nasal
swab
andor
bal
describ
microtitr
viru
neutral
test
vnt
perform
plate
use
hrt
cell
quantit
antibodi
bocv
use
duplic
row
serum
dilut
initi
challeng
viru
cytopath
bocv
usda
aphi
nvsl
ame
ia
bocv
nvsl
strain
endpoint
lowest
finalviru
test
complet
neutral
viral
cpe
titer
express
reciproc
endpoint
dilut
posit
neg
control
util
studi
bocv
use
vnt
serotest
compar
differ
osu
strain
isol
respiratori
tract
tabl
monoclon
antibodi
lot
bc
n
protein
serv
posit
control
antibodi
titer
sever
osu
strain
addit
bocv
nvsl
refer
strain
compar
determin
calv
serum
abl
neutral
viral
cpe
respect
viru
three
sera
calv
isol
two
sera
calv
isol
three
sera
anim
isol
virus
use
nvt
challeng
viru
includ
five
two
three
one
strain
fig
error
bar
repres
standard
error
mean
refer
antibodi
describ
use
studi
vnt
respect
osu
viru
serum
convalesc
compar
determin
calv
sera
abl
neutral
viral
cpe
respect
viru
bocv
respiratori
virus
osu
studi
along
refer
strain
mlv
vaccin
strain
examin
genom
divers
base
comparison
region
gene
brief
rna
bocv
virus
osu
studi
along
refer
enter
respiratori
mlv
vaccin
strain
prepar
use
qiagen
viral
rna
mini
kit
qiacub
per
manufactur
instruct
qiagen
inc
usa
valencia
ca
l
aliquot
extract
rna
amplifi
use
primer
set
publish
kanno
et
al
nucleotid
section
protein
gene
amplifi
includ
polymorph
region
protein
gene
use
phylogenet
analysi
previou
studi
coronaviru
amplif
confirm
base
size
amplicon
visual
agaros
gel
electrophoresi
amplicon
purifi
concentr
use
geneclean
spin
kit
per
manufactur
instruct
mp
biomed
solon
ohio
follow
quantif
use
pico
green
assay
ds
dna
invitrogen
corpor
carlsbad
ca
appropri
quantiti
dsdna
label
direct
use
big
dye
termin
chemistri
appli
biosystem
inc
foster
citi
ca
accord
manufactur
instruct
label
product
sequenc
use
abi
genet
analyz
appli
biosystem
inc
sequenc
confirm
sequenc
strand
sequenc
reaction
run
duplic
sequenc
edit
align
use
sequench
gene
code
corpor
ann
arbor
mi
final
phylogenet
molecular
evolutionari
analys
conduct
use
mega
version
tamura
k
peterson
peterson
n
stecher
g
nei
kumar
molecular
evolutionari
genet
analysi
use
maximum
likelihood
evolutionari
distanc
maximum
parsimoni
method
molecular
biolog
evolut
analysi
done
use
clustalw
base
unpair
geometr
mean
analysi
support
bootstrap
replic
refer
sequenc
genbank
use
analysi
list
tabl
genbank
access
number
gener
sequenc
list
tabl
endpoint
dilut
reflect
highest
dilut
serum
inhibit
growth
viru
serolog
related
express
calcul
ratio
p
state
percentag
heterolog
vn
valu
compar
homolog
vn
valu
use
follow
formula
ba
vn
titer
strain
b
use
antiserum
aa
vn
titer
strain
use
antiserum
statist
signific
evalu
use
analysi
varianc
anova
least
signific
differ
lsd
method
level
signific
p
conjunct
field
strain
spike
protein
code
sequenc
amplifi
sequenc
one
refer
strain
receiv
nation
veterinari
servic
laboratori
nebraska
one
vaccin
strain
amplifi
vial
modifi
live
vaccin
calfguardpf
bcv
align
gener
sequenc
reveal
sequenc
ident
among
strain
tabl
multipl
isol
anim
case
sequenc
ident
addit
six
cluster
virus
sequenc
ident
note
cluster
identifi
tabl
dendogram
shown
fig
construct
use
sequenc
one
repres
six
cluster
shown
bold
letter
sequenc
remain
bocv
sequenc
ident
bocv
character
studi
phylogenet
analysi
use
sequenc
gener
studi
field
strain
bocv
sequenc
refer
strain
vaccin
strain
result
dendogram
two
major
clade
clade
compos
refer
strain
associ
enter
diseas
vaccin
strain
multival
vaccin
prevent
scour
calv
clade
compos
bocv
field
strain
panel
assembl
studi
refer
strain
associ
respiratori
diseas
winter
dysenteri
three
subgroup
b
c
fig
evid
clade
subgroup
made
refer
strain
previou
studi
three
isol
bocv
field
strain
panel
two
subgroup
made
entir
isol
bocv
field
strain
panel
studi
describ
instanc
bocv
ident
tabl
ident
virus
differ
studi
time
howev
instanc
calv
nonident
bocv
subclad
also
mixtur
multipl
bocv
subclad
includ
calv
osu
studi
cattl
purchas
auction
market
isol
like
reflect
exposur
multipl
sourc
virus
convalesc
sera
collect
anim
expos
bocv
strain
clade
subgroup
could
use
differenti
virus
clade
fig
error
bar
fig
repres
standard
error
mean
contrast
convalesc
sera
collect
anim
expos
bocv
strain
clade
subgroup
b
c
statist
signific
p
greater
neutral
power
strain
clade
oppos
one
strain
clade
statist
signific
differ
neutral
clade
subgroup
use
sera
evalu
bocv
initi
identifi
enter
pathogen
vaccin
avail
control
bocv
calv
howev
recent
bocv
isol
conjunct
brd
feeder
stockyard
cattl
rais
sever
question
differ
bocv
associ
enter
diseas
bocv
associ
respiratori
diseas
bocv
evolv
time
recent
isol
detect
differ
refer
strain
isol
year
ago
differ
recent
isol
strain
vaccin
strain
practic
signific
previous
protein
code
sequenc
compar
nine
bocv
isol
isol
dysenteri
case
korean
cattl
compar
previous
character
bocv
strain
nine
isol
close
relat
recent
isol
respiratori
bcov
strain
ok
enter
bcov
strain
prototyp
bocv
refer
strain
mebu
hypothes
bocv
evolv
time
may
diverg
enter
tropism
dual
respiratori
enter
tropism
similarli
kanno
et
al
compar
protein
code
sequenc
bocv
collect
japan
refer
strain
conclud
isol
distinct
genet
diverg
prototyp
enter
bocv
strain
mebu
quebec
kakegawa
studi
report
herein
expand
observ
addit
compar
protein
code
sequenc
recent
us
isol
refer
strain
also
compar
strain
vaccin
strain
conduct
antigen
comparison
use
convalesc
sera
cattl
expos
bocv
result
suggest
bocv
strain
current
circul
us
similar
recent
japanes
korean
strain
diverg
prototyp
bocv
strain
isol
case
year
ago
antigen
differ
recent
strain
prototyp
strain
mebu
result
consist
diverg
bocv
time
whether
diverg
associ
increas
tropism
respiratori
tissu
result
increas
associ
respiratori
diseas
matter
futur
studi
differ
cell
tropism
result
differ
clinic
present
observ
coronaviruess
transmiss
gastroenter
viru
tgev
porcin
respiratori
coronaviru
prcv
pathogen
swine
cocircul
swine
herd
tgev
replic
primarili
enter
tract
prcv
replic
almost
exclus
respiratori
tract
case
porcin
coronavirus
chang
cell
tropism
associ
variat
gene
appear
prcv
may
delet
mutant
tgev
comparison
tgev
prcv
larg
delet
region
gene
minor
delet
gene
theoriz
base
studi
use
tgev
mutant
mutat
locat
gene
affect
tissu
tropism
virul
differ
observ
studi
strain
use
vaccin
control
bocv
associ
enter
diseas
recent
isol
bocv
suggest
vaccin
may
fulli
protect
bocv
isol
current
circul
research
need
determin
bocv
diverg
enter
tropism
dual
respiratori
enter
tropism
control
bocv
reduc
brd
loss
studi
divers
bocv
subclad
cattl
observ
calv
sampl
arriv
cattl
like
purchas
multipl
herd
auction
market
divers
point
need
determin
potenti
immun
provid
broad
rang
protect
heterolog
bocv
anoth
point
cattl
studi
found
shed
virus
arriv
short
arriv
thu
immun
control
bocv
perform
prior
cattl
expos
viru
market
ship
channel
bocv
control
program
use
vaccin
would
appear
best
done
origin
breed
herd
bocv
becom
respiratori
pathogen
differ
strain
use
vaccin
enter
diseas
may
provid
protect
expect
immun
studi
perform
determin
current
vaccin
bocv
clade
provid
adequ
protect
bocv
subclad
potenti
bocv
clade
strain
might
develop
immunogen
includ
subclad
well
ideal
vaccin
efficaci
would
util
anim
challeng
clinic
sign
lesion
due
virul
challeng
demonstr
protect
anoth
approach
approv
might
util
reduct
viral
shed
measur
vaccin
efficaci
also
surveil
program
maintain
determin
addit
bocv
clade
present
cattl
popul
studi
initi
studi
us
examin
genet
differ
among
bocv
isol
respiratori
tract
cattl
variou
oklahoma
studi
two
clade
identifi
bocv
three
subclad
clade
b
c
antigen
differ
detect
base
viru
neutral
test
use
multipl
strain
subclad
result
indic
genet
antigen
differ
thu
result
potenti
applic
immunogen
mlv
vaccin
avail
us
member
bocv
clade
respiratori
isol
bocv
clade
current
mlv
vaccin
test
protect
bocv
clade
virus
bocv
clade
virus
might
incorpor
exist
bocv
clade
vaccin
dr
robert
fulton
prior
research
support
pfizer
anim
health
consult
bovin
respiratori
diseas
pfizer
anim
health
access
studi
result
provid
financi
support
antigen
genet
studi
influenc
studi
